Helicase proteins catalyze the unwinding of the doublestranded nucleic acids in order to initiate replication and transcription (34) . The two processes, translocation and strand separation, occur simultaneously during nucleic acid unwinding and use energy from ATP hydrolysis (3, 11, 35, 37, 58) . The exact mechanism of helicase action is still unclear, although a number of models have been proposed. In these models, the helicase protein could be active as a monomer, dimer, or hexamer and the nucleic acid binding site could reside at multiple sites on a monomer or on separate subunits of an oligomeric helicase (1, 4, 33) . Experiments that address the active state of the helicase enzyme represent the first step towards a total understanding of the mechanism of helicase unwinding for this virus.
Previously, we identified a helicase activity in the VP6 protein, a nucleocapsid-associated protein of bluetongue virus (BTV). BTV, which is in the Reoviridae family, has a genome of 10 double-stranded RNA (dsRNA) segments, each of which has two cRNA strands with end-to-end complementarities (12) . Purified VP6 in isolation has the ability to unwind BTV dsRNA in vitro (52) . Like most other nucleic acid-unwinding proteins, VP6 binds a single-stranded region for initial attachment; however, it could also bind to and initiate helicase activity on a perfect duplex RNA (14, 16, 47, 52) . Sequence comparisons of a large number of helicases from different organisms have identified various common functional motifs, including putative sequences for RNA binding, ATP binding, and helicase function as well as a Walker A motif commonly present in nucleoside triphosphate (NTP) binding and hydrolyzing enzymes (5, 7, 8, 20, 27, 28, 31, 50, 54) . A number of similar, though not identical, functional motifs can be recognized in the BTV VP6 protein when it is compared with other helicases for which crystal structures are available (12, 24, 29, 56, 57) . The 35-kDa VP6 protein is one of three minor proteins of BTV located within the core of BTV along with the dsRNA segments and two other proteins (VP1 and VP4) that are involved in viral RNA replication (for a review, see reference 46). The core is mainly composed of two major proteins, VP3 and VP7, apart from the three minor proteins and viral genome. In the mature virions, the core is enclosed by an outer capsid formed by two other major proteins, VP2 and VP5, both of which are lost during the initial stages of virus entry and penetration into the host cells. Within the cytoplasm, the BTV core is transcriptionally active and repeatedly transcribes and caps viral mRNA from each of the 10 dsRNA segments. The newly synthesized RNA transcripts subsequently extrude from the core into the cytoplasm to initiate viral protein translation (46) . There is a considerable body of information available regarding the BTV core structure, determined both by cryoelectron microscopy (cryo-EM) and by X-ray crystallography (17, 18, 43) . However, although the structures of VP3 and VP7, the two major components of the viral core, have been resolved in detail, the structural organization of the three minor proteins that constitute the transcriptase complex, which is closely associated with the dsRNA genome, have not been defined at atomic resolution. Recent cryo-EM studies of core-like particles have suggested the location and the overall structural organizations of the two minor proteins, VP1 and VP4 (P. Roy and B. V. V. Prasad, unpublished data). The functions of these two proteins, namely the RNA polymerase and the mRNA capping enzyme, have also been established previously (44, 45, 55) . It was also possible to assign a role to the smallest minor protein, VP6, in the transcription complex, in that it has RNA helicase activity (52) . However, neither the mechanism of helicase activity nor and the oligomeric nature of VP6 has been firmly established. In this study, we map the functional domains of the various individual activities associated with the VP6 helicase. In the absence of structural information, we have identified the putative ATPase, ATP hydrolysis, RNA binding, and RNA unwinding domains through alignment with those of known helicases. Site-specific mutagenesis was then used on each of the putative helicase motifs to confirm a functional role. To produce sufficient protein for analysis, each VP6 mutant was expressed by using the baculovirus expression system and the recombinant mutant protein was purified. The effects of these altered residues on VP6 activities were subsequently determined by in vitro assays. To determine the oligomeric nature of VP6, protein was purified at homogeneity and analyzed for its molecular form in solution both alone and following incubation with single-stranded RNA (ssRNA) or dsRNA. We show that, in common with other known helicases, the protein is hexameric and forms a discrete ring-like structure when complexed with its substrate.
MATERIALS AND METHODS
Virus and cells. Autographa californica nuclear polyhedrosis virus and the recombinant baculoviruses were propagated in the Spodoptera frugiperda (Sf9) insect cell line at 28°C in serum free SF900 II medium (Gibco) as described elsewhere (25) .
Site-directed mutagenesis and isolation of recombinant baculoviruses expressing mutant VP6 proteins. The plasmid pAcBTV10.9 (47) , which contains the DNA sequence encoding the BTV serotype 10 VP6 protein, was employed directly for site-directed mutagenesis with the QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, Calif.) according to the vendor's instructions. The oligonucleotides used for mutagenesis and the resulting amino acids changes are as follows: K 110 N, AGAATGCTAACAGAGGAGATGGAAACGTTGGA GGAGGAGG; D 157 N, GCATGCTAAAGCCGTTGAGCAAGGAGGACGC AAGCAGAGG; R 205 Q, GAAGATTGATGTTTACAGGAATGAGGTTCCA GCTCAGATC. Mutated sequences in the recombinant plasmid were confirmed by sequence analysis (48) . The Lipofectin technique (10) was used to construct a monolayer of Sf9 cells with recombinant transfer vectors and BSU361 triple-cut A. californica nuclear polyhedrosis virus DNA (26) . Recombinant baculoviruses were selected on the basis of their LacZ-negative phenotype and plaque purified as described elsewhere (42) .
Expression and purification of BTV-10 VP6 wild-type and mutant proteins. S. frugiperda (Sf9) insect cells were infected with recombinant baculoviruses at a multiplicity of infection of 5 PFU/cell and incubated in serum-free SF900 (Gibco) medium for 48 h at 28°C. The recombinant wild-type (47) and mutant VP6 proteins were purified as described previously (52) .
Gel filtration chromatography. The molecular weight of each recombinant baculovirus expressing VP6 was determined on a Pharmacia Hi-load 16/60 Superdex-200 column in a buffer containing 20 mM Tris-HCl (pH 7.5) and 20 mM NaCl. The flow rate was 0.3 ml/min, and 1-ml fractions were collected and analyzed by sodium dodecyl sulfate (SDS)-10% polyacrylamide gel electrophoresis (PAGE). Molecular mass standards were obtained from Pharmacia.
Protein cross-linking. Purified VP6 protein was cross-linked with 0.1% glutaraldehyde as follows. Cross-linking reactions were performed at room temperature at a final concentration of 2 M VP6 in cross-linking reaction buffer (20 l) containing 20 mM Tricine (pH 8.3), 50 mM NaCl, 20% glycerol, 5 mM MgCl 2 , and 3 mM dithiothreitol (DTT). Samples were preincubated on ice for 15 min prior to the addition of glutaraldehyde (EM grade; Electron Microscopy Science) to a final concentration of 0.1%. Reactions were quenched after 30 min by adding 2 M Tris-HCl (pH 6.8). Samples were resolved on SDS-9% PAGE and stained with Coomassie brilliant blue.
Preparation of in vitro transcripts for RNA binding. RNA transcripts representing full-length plus-strand RNA of BTV segment 7 were prepared by in vitro transcription of plasmid pEC-10B7-H(␦) DNA which contains a full-length cDNA copy of BTV segment 7 in pUC-119 flanked by an upstream T7 promoter and downstream hepatitis ␦ ribozyme and T7 polymerase terminator (41) . The T7 transcription reaction mixture was formed by using the Ribomax large-scale transcription kit (Promega, Madison, Wis.) under the conditions indicated by the vendor with the following modifications. Each transcription reaction mixture contains the supplied buffer, 4 mM concentrations of each NTP, 1 to 2 g of DNA, and 2 l of the supplied enzyme mix in a 20-l final volume. The reaction mixtures were incubated at 37°C for 3 h. Two units of RNase-free DNase were added, and incubation continued for a further 15 min at 37°C. Following extraction with phenol-chloroform, the RNA was passed through a G-25 spin column (Pharmacia) to remove unincorporated NTPs and quantified by a spectrophotometer (Beckman DU530). The 5Ј end of the RNA was radiolabeled with 32 P by using [␥-
32 P]ATP (50 Ci) and T4 polynucleotide kinase. Excess [␥-32 P]ATP was removed by passing through a G-25 column (Pharmacia).
Velocity sedimentation analysis. Purified VP6-bound RNA was applied onto a 15 to 35% (vol/vol) glycerol gradient made in 20 mM Tris-HCl (pH 8), 100 mM NaCl, 3 mM DTT, and 3 mM MgCl 2 and sedimented at 60,000 rpm for 3 h in a Beckman VTI 65 rotor at 4°C. Molecular mass markers in this gradient were from Pharmacia high-molecular-mass calibration kits. The standard consists of the following proteins: catalase (4 ϫ 58 ϭ 232 kDa), lactate dehydrogenate (4 ϫ 36 ϭ 140 kDa), and ovalbumin (43 kDa). Fractions were collected from the bottom of the tube and analyzed by SDS-PAGE and by Western blotting.
ATPase activity assays. ATPase activity was assayed by measuring the extent of [␥-
32 P]ATP hydrolysis by using polyethyleneimine-cellulose chromatography followed by autoradiogram essentially as described previously (52) . The efficiency of the activity of each mutant was calculated from the intensity of the spot as measured by phosphorimager compared with that of wild-type VP6, which was set at 100%.
Cross-linking of the oxidized ATP with VP6. A cross-linking experiment was performed according to the previously established protocol (52) . Briefly, [␣-32 P]ATP (400 Ci/mmole) was oxidized with 0.5 mM sodium periodate and 0.5 mM HCl, excess periodate was removed, and 0.5 g of protein was incubated overnight with 0.5 M oxidized ATP in 50 mM Tris-HCl (pH 7.5), 5 mM MgCl 2 , and 1 mM DTT as described previously (52) . Protein complexes were analyzed by SDS-10% PAGE followed by autoradiography. The efficiency of each mutant was calculated by phosphorimager scanning and compared to that of the wild type, which was arbitrarily set at 100%.
Labeling of RNA oligonucleotide. RNA oligonucleotides were purchased from Dharmacon Research (Lafayette, Colo.). The oligos were constructed by using standard methods (13) and are the following: 5Ј-AGAGAGAGAGGUUGAG AGAGAGAGAGUUUGAGAGAGAGAG-3Ј (40-mer, template strand) and 5Ј-CAAACUCUCUCUCUCUCAAAAAAAAA-3Ј (26-mer, release strand). The RNA oligos were subsequently 5Ј-end labeled with [␥-32 P]ATP by using T4 polynucleotide kinase (New England Biolabs) according to the manufacturer's protocol. Unlabeled nucleotides were removed by using Sephadex G-50 spin columns (Pharmacia) and stored at Ϫ20°C in sterile H 2 0 containing 0.25 U of RNasin (Promega) per l.
RNA binding assays. A UV cross-linking (61) method was employed to measure the RNA binding ability of the protein. Binding of small, labeled RNA oligonucleotides to the BTV VP6 and the mutant proteins was compared by gel mobility shift assay. One-half microgram of the wild-type or mutant helicase protein was incubated with 1.3 pmol of radiolabeled ssRNA (26-mer) oligonucleotides in 20 l of helicase reaction buffer (30 mM Tris-HCl [pH 7.5], 3 mM MgCl 2 , 10 mM DTT, and 1 l of RNasin [Promega] ). The binding reaction mixture was incubated at 37°C for 15 min, and then the reaction was terminated by adding 5ϫ RNA loading dye containing 0.5% Nonidet P-40 and subsequently analyzed on a 4% polyacrylamide-0.5ϫ Tris-borate-EDTA gel. The bound complex was visualized by autoradiography.
Preparation of partial dsRNA substrate. Two RNA oligos were combined at a molar ratio of release strand (labeled) to template strand (unlabeled) of approximately 1:10 in a solution containing 50 mM Tris-HCl (pH 7.5), 0.5 mM NaCl, and 1 mM EDTA. The mixture was boiled for 10 min, transferred to 65°C for 30 min, and incubation continued overnight at 25°C. The hybridized product was further purified through a Sephadex G-75 spin column (Pharmacia). Eluted duplex RNA was stored at Ϫ20°C for further use.
Helicase assays. The helicase assay was done as described previously (52) . Briefly, a duplex unwinding reaction was performed in a 16-l volume with 30 mM Tris-HCl (pH 7.5), 3 mM MgCl 2 , 10 mM DTT, 5 mM ATP, 1 l of RNasin (Promega), 1 nM VP6 protein, and 1 nM 32 P-labeled RNA duplex. The reaction mixture was incubated at 37°C for 30 min, and the reaction was terminated by the addition of 4 l of 5ϫ SDS-PAGE sample buffer and analyzed by 12% (wt/vol) nondenaturing PAGE in Tris-glycine buffer followed by autoradiography as described previously (52) .
Electron microscopy analysis. VP6 was incubated with RNA and diluted to 0.1 mg/ml, adsorbed to a carbon-coated copper grid, and stained with a 1% solution of uranyl acetate. Images were visualized by an electron microscope (Hitachi Instruments, Pleasanton, Calif.).
RESULTS
Rationale for selection of residues within VP6 to generate VP6 mutants: generation and purification of recombinant VP6 proteins. Purified VP6 possesses a number of properties associated with its helicase function (52) . Our laboratory has previously shown that it binds ATP, exhibits an RNA-dependent ATPase activity in the presence of Mg 2ϩ , which involves removal of the terminal phosphate, and in vitro unwinding of duplex RNA in the presence of ATP. For helicase activity, an essential prerequisite is the hydrolysis of NTP to generate the required energy for nucleic acid unwinding. In addition, helicases must possess an ATP binding domain and at least two nucleic acid binding sites in order to maintain contact with the substrate before and after unwinding (33) . These features have not yet been confirmed on VP6 by identification followed by mutagenesis. We used the published crystal structure data of hepatitis C virus (HCV) NS3 helicase as the predominant guide for the mutational analysis of VP6 (6, 22, 24, 54, 59) .
Three mutants were constructed by site-directed mutagenesis. One of these was designed to disrupt the ATP binding activity of VP6 by replacing a conserved positively charged lysine residue within the putative ATP binding domain ( Fig. 1) with an uncharged residue. The G/AXXGXGKS/T sequence, known as the Walker A motif, is found in nearly all NTP hydrolyzing enzymes and is also responsible for NTP binding activity (32, 54, 57) . Previous structural studies demonstrated that the conserved lysine residue in the Walker A motif is involved in binding to the ␤ phosphate of the NTP (53, 56) . This domain is represented by ANRGDGKV in BTV VP6 (conserved residues are in boldface). In the NS3 helicase of HCV, it was shown that changing a lysine (K) in the NTP binding domain to E or N changed drastically the ability of NS3 to bind ATP and unwind RNA duplexes (23, 54) . Therefore, the lysine at position 110 of the VP6 protein (K 110 N) was replaced by an asparagine (K 110 N), creating AXXGXGN 110 V. In addition to G/AXXGXGKS/T, two other motifs (DEAD or DEXH and TAT or SAT) have also been identified for the ATP hydrolysis activity of helicases (54, 57) . The glutamic acid (E) of the Walker B (DEXH) motif may serve as a Lewis base during the hydrolysis of ATP, as previously demonstrated in PcrA DNA helicase (56) . In VP6 there are neither obvious DEAD or DEXH domains nor SAT or TAT domains, but a DEVP domain, very similar domain to DEAD, exists at residues of amino acids (aa) 156 to 159 (Fig. 1) . To ascertain whether the conserved DE residues within this DEVP domain of VP6 have a role like the Walker B motif and are involved in the ATP hydrolysis, the glutamic acid of this domain was replaced by an asparagine (E 157 N).
The RXGRXXR motif is important for the RNA binding and unwinding and is known as conserved motif VI of helicases (20, 21, 39) . This highly positively charged motif (Fig. 1) is easily identifiable in VP6 and is represented by RGGRKQR (aa 205 to 211), consistent with the role of RNA binding (conserved residues are in boldface). This sequence is conserved in the VP6 of other BTV serotypes. To investigate whether this domain constitutes the main RNA binding site, a substitution mutation at amino acid position 205 (R 205 Q) was introduced.
Each mutant construct was used to generate a recombinant baculovirus, and each mutant protein was expressed in an insect cell line. The expression of each recombinant VP6 was deter- mined by SDS-10% PAGE followed by Coomassie blue staining and Western analysis with an anti-BTV10 antiserum (data not shown). All recombinant proteins were subsequently purified by using our established purification methods (see Materials and Methods). SDS-PAGE analysis of the purified proteins showed that the purity of each was ϳ90%, which was suitable for direct biochemical analysis (Fig. 2) . Moreover, the solubility and level of expression of mutant VP6 proteins were equivalent to that of wild-type VP6, indicating that the mutagenesis did not grossly affect the physical properties of the protein.
ATPase activity and ATP binding activity of the VP6 mutants. The NTP hydrolysis activity of the helicase enzyme hydrolyzes NTP to nucleoside diphosphate and phosphate, and this step is important for helicase movement and RNA unwinding. Our previous data demonstrated that ATP was the preferred NTP for VP6-catalyzed RNA unwinding. To map the ATPase activity in VP6, we employed the in vitro ATPase assay system established previously (52) . All mutant proteins displayed reduced activity when compared to wild-type VP6 protein. Mutation in motif I (AXXGXGK 110 V) affected ATPase activity drastically and showed only 10% of the wildtype activity (Fig. 3) . Mutation at putative motif II (DE 157 XX), in contrast, had very little effect, and approximately 90% of the activity was retained by the mutant, suggesting that this domain does not play a major role in VP6-catalyzed ATP hydrolysis (Fig. 3) . Mutation R 205 Q at the RNA binding motif (RXG RXXR) also significantly reduced ATPase activity and showed only 10% of that achieved by the wild-type protein (Fig. 3) , indicating that RNA binding activity may have a role in ATPase activity, either directly or indirectly. The results clearly demonstrate that the K 110 of conserved motif I plays a crucial role in ATP hydrolysis and indicates that the activity is likely to be RNA dependent.
The ATP binding activity of the VP6 protein was examined by cross-linking with [␣-
32 P]ATP as described previously. The labeled ATP-bound protein was resolved by SDS-10% PAGE and autoradiographed (Fig. 4) ; protein that displayed the ATP binding activity was covalently bound to ATP and radiolabeled. Wild-type VP6 was efficiently labeled by this assay as reported previously (52); however, mutant K 110 N had completely lost ATP binding activity, as expected (Fig. 4) . The VP6 E 157 N mutant within the DEVP motif, believed to be a DEAD/ DEXH Walker B motif, did bind ATP but did so less efficiently (ϳ75 to 80%) than the wild-type protein (Fig. 4B) . The third mutant, R 205 Q, bound ATP with similar efficiency to that of the wild type (data not shown), indicating that this residue is not involved in the ATP binding activity of the protein.
RNA binding and helicase activity of the mutant proteins. We analyzed the RNA binding activity of VP6 and the mutants by using optimized conditions for helicase enzyme activity (in the presence and absence of ATP) with a 26-mer ssRNA. Previously, in our laboratory, it was shown that VP6 binds nucleic acids in the presence of SDS with no apparent specificity (47) . Here, we used non-BTV RNA to study the in vitro binding capacity of the VP6 and the mutant proteins. RNA binding efficiency was measured by gel mobility shift assay (Fig.  5) . The data indicate that VP6 is able to form a stable complex with the ssRNA probe in absence of ATP. Among the three mutants tested (K 110 N, E 157 N, and R 205 Q), the mutant R 205 Q, a mutation at the putative RNA binding site, essentially eliminated binding activity (Fig. 5B) , retaining less than 5% of the activity shown by the parental sequence. In contrast, at least 50% of the RNA binding capacity was retained by the other Helicase activity was assessed by the capacity of each purified protein to unwind a labeled partial duplex made from short 26-mer 32 P-labeled oligonucleotide annealed to a 40-mer unlabeled template as described in Materials and Methods. The data that we have obtained from these experiments indicate that mutant K 110 N and R 205 Q both lost 90% of their ability to unwind the partial duplex RNA, whereas mutant E 115 N was only partially affected (Fig. 6 ). These data suggest that E 115 is not directly involved in helicase activity.
FIG. 4. ATP binding activities of the wild-type (WT) and mutant VP6 proteins. One-half microgram of protein was mixed with 0.5 M oxidized [␣-
32 P]ATP (400 Ci/mmol) in 50 mM Tris-HCl (pH 7.5), 5 mM MgCl 2 , and 1 mM DTT. The reaction was allowed to proceed overnight on ice in the presence of 7.5 mM NaBH 3 CN. The reaction was stopped by the addition of 5ϫ SDS sample buffer, the mixture was boiled, and protein complexes were loaded onto an SDS-10% PAGE gel. After electrophoresis, the gel was dried and autoradiographed to determine the distribution of labeled proteins. 
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The overall results clearly indicate that there is a strong correlation between ATPase activity and RNA helicase activity of VP6. Unwinding of the dsRNA is an ATP-dependent process, and ATP hydrolysis is essential for the helicase activity. Both of these characteristic features are shown by VP6, and the putative domains identified by homology with known helicases appear to be functionally significant domains of VP6.
Purified VP6 forms a multimer in solution. Helicase proteins generally function as hexamers. However it is not clear whether VP6 exists in a multimeric form consistent with the expectations of the confirmed biochemical analysis. We have addressed this issue by investigating the oligomeric nature of VP6 by using recombinant wild-type VP6 expressed by a previously generated recombinant baculovirus (47) . Recombinant protein was purified to 90% (Fig. 7A, inset) homogeneity by ammonium sulfate precipitation followed by high-performance liquid chromatography, and the molecular weight in solution was initially investigated by mass spectrophotometer (MS). When approximately 5 g of protein was subjected to MS analysis, both dimeric and tetrameric forms of VP6 were detectable (Fig. 7A) , but the majority of the protein remained as a monomer, suggesting that the multimers formed by VP6 are not stable under these conditions.
To stabilize the VP6-VP6 interactions, protein cross-linking was used by incubation of purified VP6 with 0.1% glutaraldehyde. When the products of this reaction were analyzed by SDS-10% PAGE, a number of protein species ranging in size from 35 to 200 kDa were detectable by Coomassie blue staining (Fig. 7B ) and the molecular weight increments of the visualized bands would be consistent with a range of VP6 oligomers from monomer up to hexamer, although the majority of the species were dimeric (Fig. 7B) . The identities of the oligomeric forms as VP6 were confirmed by Western blotting with anti-BTV antisera (data not shown). It is noteworthy that unmodified VP6 generally migrates slightly slower than its predicted molecular mass in SDS-10% PAGE but that, after glutaraldehyde treatment, the protein migrates near to the 37-kDa position (Fig. 7B) .
MS analysis and a protein-protein cross-linking experiment demonstrated that the VP6 protein was capable of forming oligomers in solution, but VP6 dimers predominated and no uniform oligomeric state was defined.
VP6 forms defined hexamers in the presence of BTV transcripts and assembled into distinct virus-like structures. It is likely that multimerization of VP6 could be induced and stabilized by the addition of BTV RNA. Indeed, it has been shown previously that certain helicase proteins form specific oligomeric structures only in the presence of nucleic acid or NTPs (2, 11, 15, 38, 40) . Such a possibility was therefore investigated for VP6 by incubating purified protein with in vitrosynthesized exact copy RNA transcripts of BTV segment 7. Electrophoresis mobility shift assays showed that with a saturated amount of VP6 protein, 100% RNA binding could be achieved (data not shown). The formation of a stable RNAprotein complex was further confirmed by gel filtration. RNAbound VP6 protein was analyzed by a Hi Load Superdex-200 column. The elution profile when compared with the molecu- (Fig. 8) .
The oligomeric status of VP6 following RNA binding was investigated by glycerol gradient sedimentation as previously described (30) . Gradients were fractionated, and the presence of VP6 was assessed by analysis by SDS-10% PAGE (Fig. 9A) .
The two predominate peaks were identified, which, when compared to molecular mass markers analyzed in parallel, suggested that the slowest migrating peak corresponded to VP6 monomers (ϳ35 kDa) while the second peak represented a hexameric form (Ͼ210 kDa).
Glycerol gradient fractions containing the putative hexameric and monomeric forms of VP6 were analyzed by electron microscopy. The images of the putative hexameric fraction showed a ring-like structure (Fig. 9B, upper panel) very similar to the structures reported for other viral helicases (2, 11, 15, 38, 40) . Similar apparent ring-like structures of hexamers were also formed when dsRNA was used (Fig. 9B, lower panel) .
DISCUSSION
The data presented in this report confirm that VP6 is a typical RNA helicase protein with all the functional criteria for its identification mapped to specific sequences. Helicases identified from different organisms have been grouped into three general super families (SF), SFI, SFII, and SFIII, on the basis of conserved motifs (20, 21, 28, 50) . At first glance, VP6 does not appear to belong to any of these families, as it does not possess the conserved sequences typical of the known helicases although partially matching motifs are present. The helicase 1 protein of reovirus (Bisaillon M1997 tial features are shared by all helicases: ATP hydrolysis, which releases the energy required for helix destabilization, and nucleic acid binding site(s), which maintain contact with the nucleic acid that is to be unwound (33) . RNA helicases also have a particular signature sequence, the DEAD box, or DECH box, which is responsible for forming the protein-ATP complex in the presence of Mg 2ϩ (7, 8, 28) . BTV VP6, with 328 aa, has a high proportion of hydrophilic and positively charged residues and inherently binds both ssRNA and dsRNA (47) . It was also shown that VP6 possesses dsRNA unwinding activity in the presence of ATP and Mg 2ϩ (52) and is capable of unwinding perfect RNA duplexes in vitro, unlike most helicases, which require a single-stranded region for initial attachment (47, 52) . Surprisingly, however, it does not have the canonical DEAD box or DEXH signature motif, although other helicase motifs, such as those for RNA binding, ATP binding, and ATP hydrolysis, are present. Our studies used site-specific mutagenesis together with expression and purification and various biochemical assays to obtain direct evidence of the importance of these putative motifs in VP6 function.
The most N-terminal motif, ANRGDGKV (aa 104 to 111), of VP6 is comparable with the N-terminal conserved motif G/AXXGXGKS/T of other helicases. This motif forms a phosphate binding loop and is required for ATP binding and hydrolysis activities (56) . The lysine of the GKS motif is directly involved in binding the ␤ and ␥ phosphates of the NTP. Our findings that this sequence is also required for VP6 ATP hydrolysis and helicase activity suggests that the VP6 sequence may form similar loops. At least three RNA helicases have been well characterized: the eukaryotic translation initiation factor 4A (eIF-4A) mouse helicase protein, which belongs to the DEAD box family of proteins (39) , and two members of the DEXH family, vaccinia virus NPH II protein (19) and HCV NS3 helicase protein (23, 54) . For eIF-4A, replacement of the lysine residue of the GKT motif with glutamine severely reduced ATP binding and resulted in the complete loss of ATP hydrolysis and RNA helicase activity (39) . Similarly, replacement of the lysine in the GKS motif of HCV NS3 helicase with asparagine (N) completely abolished ATPase activity, ATP binding activity, and RNA unwinding activity (54) . In VP6, replacement of lysine (K 110 ) in this motif with asparagine also affected ATP binding, ATP hydrolysis, and RNA unwinding. These data suggest that VP6 helicase activity, like that of all other helicases, is dependent on ATP hydrolysis.
The common conserved helicase RNA binding motif, RXG RXXR, is shared by VP6 protein and is represented by RRG RTGR (aa 205 to 211). RNA binding activity was completely abolished in eIF-4A variants with mutations within this motif (39) . Similarly, changes in the first arginine in the RKGRVGR of the vaccinia virus NPH II protein or HCV NS3 helicase NS3 protein severely reduced RNA binding activity (19, 54) . Mutational analysis in HCV NS3 strongly suggests that the first arginine residue forms hydrogen bonds with the key residues involved in RNA binding (31, 54) . As expected, substitution at a single residue in this motif of BTV VP6 severely affected RNA binding and inhibited RNA unwinding activity. In addition, ATP hydrolysis was impaired, indicating that all three functions are interlinked and depended on the same specific sequences and structure of the protein. Our data indicate that VP6 is able to form a stable complex with ssRNA in the absence of ATP. A similar effect was observed for the NS3 helicase of HCV (13) and also for the helicase domain of the 126-kDa replicase protein of Tobacco mosaic virus (16) .
Studies with other helicases have reported a key role for the conserved residues in the DEXD/H motif. Aspartic acid (D) can bind Mg 2ϩ and assist in orienting the Mg 2ϩ -ATP complex for ATP hydrolysis (36) . Glutamic acid (E) can serve as a Lewis base, initiating the hydrolysis of ATP as previously demonstrated in PerA DNA helicase (56) . Changing glutamic acid (E) to glutamine (Q) in the HCV helicase did not alter ATP binding but abolished ATPase activity (54) . However, as stated above, VP6 does not seem to have a DEAD-like motif, although there is a DE sequence in the context of DEVP (aa 156 to 159) in which valine may represent the alanine residue of the DEAD motif. Some helicases also have either isoleucine or cysteine residues in this position (Fig. 1) . The fourth position of this motif is often replaced by histidine in some helicases, whereas VP6 has a proline residue in this position. It is possible that only the first two residues, DE, are important for maintenance of helicase function. When we mutated E 157 to asparagine (DN 157 ), ATP hydrolysis, RNA binding, and RNA unwinding were marginally affected (90% of that shown by the wild-type protein), not at the level reported for the HCV NS3 mutant protein (54) , so it is possible that this motif may not be essential for VP6 enzyme activity.
Overall, the results obtained from this study clearly demonstrate that unwinding of RNA is an ATP-dependent process. It was instructive to compare the mutagenesis results with other well-characterized helicases like eIF-4A, HCV NS3, and vaccinia virus NPH II helicases, since all of these enzymes share common motifs and more or less similar activities. Although our results show evidence of the roles of individual amino acids in the overall function of VP6, these data do not exclude the possibility that other residues may play direct or indirect roles in the unwinding process and remain to be investigated.
Our studies also indicate that physically VP6 is similar to the other helicases. Generally, helicases are hexamers or at least exist as multimers. Our results demonstrate that the purified protein can form multimers, which, in the presence of RNA, could be stabilized as distinct ring-like particulate structures, a characteristic feature that is shared by other helicases (11, 15, 51) . A range of biochemical methods, including MS, gel filtration, protein-protein cross-linking, and density ultracentrifugation, were used to identify the oligomeric nature of VP6. Clearly detectable VP6 oligomers ranging in size from monomer to hexamer could be easily detected, but it was not possible to isolate only the higher multimers of VP6, even in the presence of a cross-linking agent.
Hexameric helicases usually assemble into a ring-shaped structure. Escherichia coli DNAB and rho proteins were the first helicase proteins reported to be hexamers, but many helicases from different organisms are now known to be active as hexamers. Moreover, electron microscopy studies have shown that they share a common ring-like structure (2, 9, 11, 15, 21, 49, 60) , a structure shared by the hexameric structures formed by the VP6-RNA complex. It is likely that the active form of VP6 has a similar structural organization, but only high-resolution cryo-EM studies or X-ray crystallography can confirm this view. It is noteworthy that other BTV RNA binding proteins, VP1 (polymerase), VP4 (capping enzyme), and NS2 (role in packaging genome), do not form a similar structure (data not shown). The accumulated data on function and structure of VP6 confirm that it is a helicase with key sequence features shared with other viral and cellular helicase proteins.
